OvaScience (OVAS) Appoints Fertility Pioneer Jamie Grifo M.D., Ph.D., To Clinical Advisory Board
2/4/2014 7:59:18 AM
OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of female fertility treatments, announced today the appointment of Jamie Grifo, M.D., Ph.D., of the New York University (NYU) Fertility Center and the Division of Reproductive Endocrinology at the NYU School of Medicine, to its Clinical Advisory Board.
Help employers find you! Check out all the jobs and post your resume.
comments powered by